For this meta-analysis, we collated information from each study and concluded that the ratio of Tregs to CD4+ T cells in SSc patients tends to be lower than that in controls, but this difference was not statistically significant (Fig. 2). This evidence concerns the gene CD4 and systemic sclerosis.